Isis Pharmaceuticals (ISIS) to resume trading at 5:55PM ET
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Needham Reiterates Buy on ISIS (ISIS) Following Narrow FDA Vote for Approval of Kynamro
October 19, 2012 1:43 PM EDTYesterday an FDA Advisory panel voted 9-6 in favor of approval of Kynamro.
Analyst Chad Messer said "We believe last minute carcinogenicity concerns raised by the FDA were less of an issue for the panel than we originally thought. That said, we believe Kynamro lost at least 2 votes... More
Isis Pharmaceuticals (ISIS) Jumps 11% on Trade Resumption
October 18, 2012 5:57 PM EDTIsis Pharmaceuticals (NASDAQ: ISIS) resumes trading up 11 percent to $10.70 following FDA panel backing.... More
